Increased sensitivity to vincristine of MDR cells by the leukotriene D4 receptor antagonist, ONO-1078

Cancer Letters

Volumn 130, Issue 1-2, 1998, Pages 175-182

  Nagayama, Shuichi ^a   Chen, Zhe Sheng ^a   Kitazono, Masaki ^a   Takebayashi, Yuji ^a   Niwa, Kiyoshi ^a   Yamada, Kazutaka ^a   Tani, Ayako ^a   Haraguchi, Misako ^a   Sumizawa, Tomoyuki ^a   Furukawa, Tatsuhiko ^a   Aikou, Takashi ^a   Akiyama, Shin Ichi ^a  

^a KAGOSHIMA UNIVERSITY   (Japan)

Author keywords

MDR cells; ONO 1078; Vincristine

Indexed keywords

GLYCOPROTEIN P; LEUKOTRIENE C4; LEUKOTRIENE RECEPTOR BLOCKING AGENT; PRANLUKAST; TRITIUM; VINCRISTINE;

ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; DRUG SENSITIVITY; DRUG TRANSPORT; HUMAN; HUMAN CELL; MEMBRANE VESICLE; MULTIDRUG RESISTANCE; PRIORITY JOURNAL; RADIOASSAY;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; CHROMONES; DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, NEOPLASM; HUMANS; LEUKOTRIENE ANTAGONISTS; LEUKOTRIENE D4; NEOPLASM PROTEINS; P-GLYCOPROTEIN; TUMOR CELLS, CULTURED; VINCRISTINE;

TRITIUM;

EID: 0032516720     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(98)00132-3     Document Type: Article

References (21)

1. Akiyama S., Cornwell M.M., Kuwano M., Pastan I., Gottesman M.M. Most drugs that reverse multidrug resistance also inhibit photoaffinity labeling of P-glycoprotein by a vinblastine analog. Mol. Pharmacol. 33:1988;144-147.
2. Akiyama S., Fojo A., Hanover J.A., Pastan I., Gottesman M.M. Isolation and genetic characterization of human KB cell lines resistant to multiple drugs. Somat. Cell Mol. Genet. 11:1985;117-126.
3. Cole S.P.C. Multidrug resistance in small cell lung cancer. Can. J. Physiol. Pharmacol. 70:1992;313-329.
4. Carmichael J., Degaff W.G., Gazdar A.F., Minna J.D., Mitchell J.B. Evaluation of a tetrazolium-based semiautomated colorimetric assay. Cancer Res. 47:1987;936-942.
5. Cole S.P.C., Bhardwaj G., Gerlach J.H., Mackie J.E., Grant C.E., Almquist K.C., Stewart A.J., Kurz E.U., Duncan A.M.V., Deeley R.G. Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line. Science. 258:1992;1650-1654.
6. Cornwell M.M., Gottesman M.M., Pastan I.H. Increased vinblastine binding to membrane vesicles from multidrug-resistant KB cells. J. Biol. Chem. 261:1986;7921-7928.
7. Ford J.M., Hait W.N. Pharmacology of drugs that alter multidrug resistance in cancer. Pharmacol. Rev. 42:1990;155-199.
8. 4 receptor antagonist MK571 specifically modulates MRP associated multidrug resistance. Biochem. Biophys. Res. Commun. 208:1995;345-352.
9. Gottesman M.M., Pastan I. The multidrug transporter, a double-edged sword. J. Biol. Chem. 263:1988;12163-12166.
10. 2+-dependent cardiac transport system for glutathione S-conjugates. J. Biol. Chem. 264:1989;17343-17348.
11. Jedlitschky G., Leier I., Buchholz U., Center M., Keppler D. ATP-dependent transporter of glutathione-S-conjugates by the multidrug resistance-associated protein. Cancer Res. 54:1994;4833-4836.
12. Kartner N., Evenrnden-Porelle D., Bradley G., Ling V. Detection of P-glycoprotein in multidrug-resistant cell lines by monoclonal antibodies. Nature. 316:1985;820-823.
13. Krishnamachary N., Center M.S. The MRP gene associated with a non-P-glycoprotein multidrug resistance encodes a 190-kDa membrane bound glycoprotein. Cancer Res. 53:1993;3658-3661.
14. 4 and structurally related conjugates. J. Biol. Chem. 269:1994;27807-27810.
15. Loe D.W., Deeley R.G., Cole S.P.C. Biology of the multidrug resistance protein, MRP. Eur. J. Cancer. 32A:1996;945-957.
16. Safa A.R., Glover C.J., Sewell J.L., Meyers M.B., Biedler J.L., Felsted R.L. Identification of the multidrug resistance-related membrane glycoprotein as an acceptor for calcium channel blockers. J. Biol. Chem. 262:1987;7884-7888.
17. r 110 000 vesicular protein in non-P-glycoprotein-mediated multidrug resistance. Cancer Res. 53:1993;1457-1479.
18. Sumizawa T., Chen Z.S., Chuman Y., Seto K., Furukawa T., Haraguchi M., Tani A., Shudo N., Akiyama S. Reversal of multidrug resistance-associated protein-mediated drug resistance by the pyridine analog PAK-104P. Mol. Pharmacol. 51:1997;399-405.
19. Sumizawa T., Chuman Y., Sakamoto H., Iemura K., Almquist C., Deeley R.G., Cole S.P.C., Akiyama S. Non-P-glycoprotein-mediated multidrug-resistant human KB cells selected in medium containing adriamycin, cepharanthine and mezerein. Somat. Cell Mol. Genet. 20:1994;423-435.
20. Versantvoort C.H.M., Broxterman H.J., Bagrij T., Scheper R.J., Twentyman P.R. Regulation by glutathione of drug transport in multidrug-resistant human lung tumour cell lines overexpressing multidrug resistance-associated protein. Br. J. Cancer. 72:1995;82-89.
21. Versantvoort C.H.M., Schuurhuis G.J., Pinedo H.M., Eekman C.A., Kuiper C.M., Lankelma J., Broxterman H.J. Genistein modulates the decreased drug accumulation in non-P-glycoprotein-mediated multidrug-resistant tumour cells. Br. J. Cancer. 68:1993;939-946.